AAM
ICPT

Alpine Associates Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Alpine Associates Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,203,295
Closed -$40.8M – 50
2023
Q3 		$40.8M Buy
+2,203,295
New +$24.9M 2.14% 15

Alpine Associates Management's ICPT Position: Q4 2023 in Review

Alpine Associates Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 2,203,295 shares — an estimated $40.8M sold.

Alpine Associates Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $40.8M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Alpine Associates Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Alpine Associates Management sold 2,203,295 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $40.8M.
  • Alpine Associates Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • Alpine Associates Management's Intercept Pharmaceuticals, Inc. position peaked at $40.8M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Alpine Associates Management's 13F filing for Q4 2023, filed 7 Feb 2024.